Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Journal
Overview
publication venue for
-
Corrigendum to "DCE-MRI quantitative transport mapping for noninvasively detecting hypoxia inducible factor-1α, epidermal growth factor receptor overexpression, and Ki-67 in nasopharyngeal carcinoma patients" [Radiother Oncol (2021) 164:146-154].
2022
-
An update to the American Radium Society's appropriate use criteria of lower grade Gliomas: Integration of IDH inhibitors.
2024
-
Validation of an artificial intelligence-based prognostic biomarker in patients with oligometastatic Castration-Sensitive prostate cancer..
202.
2024
-
A phase II randomized trial of talimogene laherparepvec oncolytic immunotherapy with or without radiotherapy for patients with cutaneous metastases from solid tumors.
2024
-
Machine learning predicts conventional imaging metastasis-free survival (MFS) for oligometastatic castration-sensitive prostate cancer (omCSPC) using prostate-specific membrane antigen (PSMA) PET radiomics..
199.
2024
-
Biomarkers associated with pulmonary exacerbations in a randomized trial of nintedanib for radiation pneumonitis.
2024
-
Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancreatic cancer: a multi-center, open-label phase 2 study.
2023
-
"Primer shot" fractionation with an early treatment break is theoretically superior to consecutive weekday fractionation schemes for early-stage non-small cell lung cancer..
190.
2023
-
Cardiac radiation dose is associated with inferior survival but not cardiac events in patients with locally advanced non-small cell lung cancer in the era of immune checkpoint inhibitor consolidation..
190.
2023
-
Exploring published and novel pre-treatment CT and PET radiomics to stratify risk of progression among early-stage non-small cell lung cancer patients treated with stereotactic radiation..
190.
2023
-
Predicting the germline dependence of hematuria risk in prostate cancer radiotherapy patients..
185.
2023
-
AN0025, a novel antagonist of PGE2-receptor E-type 4 (EP4), in combination with total neoadjuvant treatment of advanced rectal cancer.
2023
-
Vital organ sparing with proton therapy for pediatric Hodgkin lymphoma: Toxicity and outcomes in 50 patients..
168.
2022
-
Pre-treatment immune status predicts disease control in NSCLCs treated with chemoradiation and durvalumab..
167.
2021
-
DCE-MRI quantitative transport mapping for noninvasively detecting hypoxia inducible factor-1α, epidermal growth factor receptor overexpression, and Ki-67 in nasopharyngeal carcinoma patients..
164.
2021
-
Clinical implementation of deep learning contour autosegmentation for prostate radiotherapy..
159.
2021
-
Non-invasive imaging prediction of tumor hypoxia: A novel developed and externally validated CT and FDG-PET-based radiomic signatures..
153.
2020
-
The relative biological effectiveness of carbon ion radiation therapy for early stage lung cancer..
153.
2020
-
Clinical outcomes, local-regional control and the role for metastasis-directed therapies in stage III non-small cell lung cancers treated with chemoradiation and durvalumab..
149.
2020
-
Utilization and factors precluding the initiation of consolidative durvalumab in unresectable stage III non-small cell lung cancer..
144.
2019
-
Are unsatisfactory outcomes after concurrent chemoradiotherapy for locally advanced non-small cell lung cancer due to treatment-related immunosuppression?.
143.
2019
-
Toward personalized dose-prescription in locally advanced non-small cell lung cancer: Validation of published normal tissue complication probability models..
138.
2019
-
Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415..
135.
2019
-
Parotid gland fat related Magnetic Resonance image biomarkers improve prediction of late radiation-induced xerostomia..
128.
2018
-
A contemporary analysis of radiotherapy effect in surgically treated retroperitoneal sarcoma..
127.
2018
-
Role of adjuvant external beam radiotherapy and chemotherapy in one versus two or more node-positive vulvar cancer: A National Cancer Database study..
129.
2018
-
Inter-institutional analysis demonstrates the importance of lower than previously anticipated dose regions to prevent late rectal bleeding following prostate radiotherapy..
127.
2018
-
Predicting hypoxia status using a combination of contrast-enhanced computed tomography and [18F]-Fluorodeoxyglucose positron emission tomography radiomics features..
127.
2017
-
Patterns of failure in limited-stage small cell lung cancer: Implications of TNM stage for prophylactic cranial irradiation..
125.
2017
-
Clinical outcomes of patients with limited brain metastases treated with hypofractionated (5×6Gy) conformal radiotherapy..
123.
2017
-
Internal and external generalizability of temporal dose-response relationships for xerostomia following IMRT for head and neck cancer..
122.
2016
-
Changes in treatment patterns and impact of radiotherapy for early stage diffuse large B cell lymphoma after Rituximab: A population-based analysis..
120.
2016
-
Urinary bladder dose-response relationships for patient-reported genitourinary morbidity domains following prostate cancer radiotherapy..
119.
2016
-
Longitudinal assessment of quality of life after surgery, conformal brachytherapy, and intensity-modulated radiation therapy for prostate cancer..
118.
2016
-
Association of intensity-modulated radiation therapy on overall survival for patients with Hodgkin lymphoma..
118.
2015
-
Patient-reported quality of life after stereotactic body radiotherapy (SBRT), intensity modulated radiotherapy (IMRT), and brachytherapy..
116.
2015
-
Prospective study of vaginal dilator use adherence and efficacy following radiotherapy..
116.
2015
-
Long-term disease control and toxicity outcomes following surgery and intensity modulated radiation therapy (IMRT) in pediatric craniopharyngioma..
114.
2014
-
Ewing sarcoma in adults treated with modern radiotherapy techniques..
113.
2014
-
Clinical and dosimetric predictors of acute hematologic toxicity in rectal cancer patients undergoing chemoradiotherapy..
113.
2014
-
A nomogram to predict loco-regional control after re-irradiation for head and neck cancer..
111.
2014
-
Axitinib sensitization of high Single Dose Radiotherapy..
111.
2014
-
Modeling positioning uncertainties of prostate cancer external beam radiation therapy using pre-treatment data..
110.
2014
-
Dose/volume-response relations for rectal morbidity using planned and simulated motion-inclusive dose distributions..
109.
2013
-
STROGAR - STrengthening the Reporting Of Genetic Association studies in Radiogenomics..
110.
2013
-
Intensity-modulated radiotherapy vs. conventional radiotherapy in the treatment of anal squamous cell carcinoma: a propensity score analysis..
107.
2013
-
Hypoxia targeted bifunctional suicide gene expression enhances radiotherapy in vitro and in vivo..
105.
2012
-
Comparison of three-dimensional versus intensity-modulated radiotherapy techniques to treat breast and axillary level III and supraclavicular nodes in a prone versus supine position..
102.
2011
-
Concurrent doxorubicin and radiotherapy for anaplastic thyroid cancer: a critical re-evaluation including uniform pathologic review..
101.
2011
-
Acquisition of MV-scatter-free kilovoltage CBCT images during RapidArc™ or VMAT..
100.
2011
-
Development, external validation and clinical usefulness of a practical prediction model for radiation-induced dysphagia in lung cancer patients..
97.
2010
-
Postmastectomy intensity modulated radiation therapy following immediate expander-implant reconstruction..
94.
2010
-
Expression of the bifunctional suicide gene CDUPRT increases radiosensitization and bystander effect of 5-FC in prostate cancer cells..
92.
2009
-
Changes in tumor hypoxia induced by mild temperature hyperthermia as assessed by dual-tracer immunohistochemistry..
88.
2008
-
Exclusive radiotherapy for primary squamous cell carcinoma of the vagina..
85.
2007
-
Intensity-modulated radiotherapy as the boost or salvage treatment of nasopharyngeal carcinoma: the appropriate parameters in the inverse planning and the effect of patient's anatomic factors on the planning results..
77.
2005
-
Comparison of end normal inspiration and expiration for gated intensity modulated radiation therapy (IMRT) of lung cancer..
75.
2005
-
Dosimetric effect of respiratory motion in external beam radiotherapy of the lung..
71.
2004
-
Risk group dependence of dose-response for biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer..
63.
2002
-
Time trends in organ position and volume in patients receiving prostate three-dimensional conformal radiotherapy..
62.
2002
-
Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET)..
62.
2002
-
Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer..
55.
2000
-
Polarographic measurements of oxygen tension in human glioma and surrounding peritumoural brain tissue..
53.
1999
-
Quantification and predictors of prostate position variability in 50 patients evaluated with multiple CT scans during conformal radiotherapy..
50.
1999
-
Brain-only metastases of small cell lung cancer; efficacy of whole brain radiotherapy. An EORTC phase II study..
46.
1998
-
Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer..
44.
1997
-
Optimization of intensity-modulated 3D conformal treatment plans based on biological indices..
37.
1995
-
Prognostic impact of transurethral resection on patients irradiated for localized prostate cancer..
35.
1995
-
An equation for the dose response of radiation-induced apoptosis: possible incorporation with the LQ model..
33.
1994
-
The potential and limitations of the inverse radiotherapy technique..
32.
1994
-
High dose-high precision in radiation oncology..
29.
1993
-
Perspectives of multidimensional conformal radiation treatment..
29.
1993
-
Chordoma: results of radiation therapy in eighteen patients..
29.
1993
-
Tumor control probability for permanent implants in prostate..
28.
1993
-
Probability of radiation-induced complications in normal tissues with parallel architecture under conditions of uniform whole or partial organ irradiation..
26.
1993
-
High dose rate gynecological applications--radiobiological considerations based on the alpha-beta model..
25.
1992
-
Analysis of cytotoxicity of 131I-labelled OC125 F(ab')2 on human epithelial ovarian cancer cell lines..
23.
1992
-
Total body irradiation for bone marrow transplantation: the Memorial Sloan-Kettering Cancer Center experience..
18 Suppl 1.
1990
-
Combined modality treatment for stage III ovarian carcinoma..
3.
1985
-
Platelet-tumor cell interaction with the subendothelial extracellular matrix: relationship to cancer metastasis..
3.
1985
-
To the Editors..
147.
2020
-
On autoradiographic studies comparing the distributions of ¹⁸F- and ¹⁴C-labeled compounds in tumor tissue specimens.
2010
-
Challenges and opportunities in primary CNS lymphoma: A systematic review.
2017
-
Dose-rate effects in external beam radiotherapy redux.
2010
-
Executive summary of American Radium Society's appropriate use criteria for the postoperative management of lower grade gliomas.
2022
-
Estimate of the impact of FDG-avidity on the dose required for head and neck radiotherapy local control.
2014
-
Is there a role for endorectal balloons in prostate radiotherapy? A systematic review.
2010
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)